2. Search Result
Search Result
Results for "

c30-

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

2

Natural
Products

1

Recombinant Proteins

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-131011
    Furanone C-30
    1 Publications Verification

    		 Bacterial Infection
    Furanone C-30 is a quorum sensing inhibitor. Furanone C-30 can effectively inhibit bacterial biofilm formation by S. mutans and its luxSmutant strain .
    Furanone C-30
  • HY-159886
    MG-C-30

    		TNF Receptor Inflammation/Immunology
    MG-C-30 is an orally active agonist for CD27 with an EC50 of 0.84 μM. MG-C-30 activates NK cells and T cell co-stimulatory signals, and enhances immune response. MG-C-30 exhibits antitumor efficacy in mouse EG7-OVA model .
    MG-C-30
  • HY-166277
    C30-Ceramide

    		Biochemical Assay Reagents Metabolic Disease
    C30-Ceramide is an ester product.
    C30-Ceramide
  • HY-117081
    C30(ω-hydroxy) Ceramide (d18:1/30:0)

    		Endogenous Metabolite Others
    C30(ω-hydroxy) Ceramide (d18:1/30:0), a sphingolipid, is an epidermis-specifically vital component of the water barrier in mammalian skin. C30(ω-hydroxy) Ceramide (d18:1/30:0) is expressed in epidermal keratinocytes and male germ cells during their differentiation and maturation. C30(ω-hydroxy) Ceramide (d18:1/30:0) deficiency in the epiderm of Elovl4 deletion or mutation mice .
    C30(ω-hydroxy) Ceramide (d18:1/30:0)
  • HY-CE00033
    (12Z,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA

    c30:6(Omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (12Z,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA (C30:6(Omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (12Z,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA
  • HY-CE00028
    (15Z,18Z,21Z,24Z)-Triacontatetraenoyl-CoA

    (15Z,18Z,21Z,24Z)-Triacontatetraenoyl-coenzyme A; c30:4(Omega-6)-coenzyme A

    		 Biochemical Assay Reagents Others
    (15Z,18Z,21Z,24Z)-Triacontatetraenoyl-CoA ((15Z,18Z,21Z,24Z)-Triacontatetraenoyl-coenzyme A) is an unsaturated fatty acyl-CoA.
    (15Z,18Z,21Z,24Z)-Triacontatetraenoyl-CoA
  • HY-CE00030
    (12Z,15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontahexaenoyl-CoA

    3-Oxo-c30:6(omega-3)-CoA

    		 Biochemical Assay Reagents Others
    (12Z,15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontahexaenoyl-CoA (3-Oxo-C30:6(omega-3)-CoA) is an unsaturated fatty acyl-CoA.
    (12Z,15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontahexaenoyl-CoA
  • HY-173177
    PSF-IN-2

    		Apoptosis MDM-2/p53 Cancer
    PSF-IN-2 (Compound (C)-30) is a PSF inhibitor with an IC50 value of 0.005 pM. PSF-IN-2 exhibits anti-cancer activity, and its IC50 value for inhibiting the proliferation of 22Rv1 cells is 0.5 μM. PSF-IN-2 activates the p53 signaling pathway by inhibiting the binding of PSF to RNA, inducing the expression of related genes, promoting apoptosis, and inhibiting the cell cycle. PSF-IN-2 can be used in cancer research .
    PSF-IN-2
  • HY-CE00005
    (15Z,18Z,21Z,24Z)-3-Oxotriacontatetraenoyl-CoA

    (15Z,18Z,21Z,24Z)-3-Oxotriacontatetraenoyl-coenzyme A; 3-Oxo-c30:4(omega-6)-coenzyme A

    		 Biochemical Assay Reagents Others
    (15Z,18Z,21Z,24Z)-3-Oxotriacontatetraenoyl-CoA ((15Z,18Z,21Z,24Z)-3-Oxotriacontatetraenoyl-coenzyme A) is an unsaturated fatty acyl-CoA.
    (15Z,18Z,21Z,24Z)-3-Oxotriacontatetraenoyl-CoA
  • HY-CE00034
    (15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontapentaenoyl-CoA

    (15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontapentaenoyl-coenzyme A; 3-Oxo-c30:5(omega-3)-coenzyme A

    		 Biochemical Assay Reagents Others
    (15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontapentaenoyl-CoA ((15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontapentaenoyl-coenzyme A) is an unsaturated fatty acyl-CoA.
    (15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontapentaenoyl-CoA
  • HY-N0086R
    N6-Methyladenosine (Standard)

    6-Methyladenosine (Standard); N-Methyladenosine (Standard)

    		 Endogenous Metabolite Influenza Virus Reference Standards Infection
    N6-Methyladenosine (Standard) is the analytical standard of N6-Methyladenosine. This product is intended for research and analytical applications. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. In Vitro: N6-methyladenosine (m6A) is selectively recognized by the human YTH domain family 2 (YTHDF2) protein to regulate mRNA degradation. N6-methyladenosine (m6A), a prevalent internal modification in the messenger RNA of all eukaryotes, is post-transcriptionally installed by m6A methyltransferase (e.g., MT-A70) within the consensus sequence of G(m6A)C (70%) or A(m6A)C (30%). N6-methyladenosine (m6A)-containing RNAs are greatly enriched in the YTHDF-bound portion and diminished in the flow-through portion . N6-methyladenosine (m6A), the most abundant internal RNA modification, functions in diverse biological processes, including regulation of embryonic stem cell self-renewal and differentiation. N6-methyladenosine (m6A) is a large protein complex, consisting in part of methyltransferase-like 3 (METTL3) and methyltransferase-like 14 (METTL14) catalytic subunits .
    N6-Methyladenosine (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: